#VisualAbstract: Capecitabine in addition to best supportive care improves progression-free survival in metastatic nasopharyngeal carcinoma
Click to read this study in JAMA Oncology.
Click to read this study in JAMA Oncology.
Click to read this study in the European Journal of Cancer.
Click to read this study in JAMA Network Open.
Click to read this study in the European Journal of Cancer.
Click to read this study in the European Journal of Cancer.
Click to read this study in the European Journal of Cancer.
Click to read this study in JAMA Oncology.
Click to read this study in JAMA Otolaryngology - Head & Neck Surgery.
Click to read this study in Otolaryngology - Head and Neck Surgery.
Click to read this study in the Journal of Clinical Oncology.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.